D A. Loblaw

Toronto, ON M4N3M5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 241 publications

Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care.

Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care.

Journal: Archivos espanoles de urologia

Published: July 13, 2026

Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.

Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.

Journal: Clinical and translational radiation oncology

Published: June 09, 2026

Case - A rare ocular recurrence of prostate cancer Adenocarcinoma metastasis to the vitreous.

Case - A rare ocular recurrence of prostate cancer Adenocarcinoma metastasis to the vitreous.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: March 18, 2026

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Journal: Cancers

Published: March 13, 2026

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer.

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer.

Journal: JAMA network open

Published: February 25, 2026

The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review.

The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review.

Journal: Current oncology (Toronto, Ont.)

Published: February 05, 2026

Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients.

Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients.

Journal: European urology oncology

Published: January 12, 2026

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Journal: European urology

Published: December 23, 2025

From Clinical Trials to Clinical Practice-Patterns of Practice Survey on Prostate SABR in Australia and New Zealand.

From Clinical Trials to Clinical Practice-Patterns of Practice Survey on Prostate SABR in Australia and New Zealand.

Journal: Advances in radiation oncology

Published: December 19, 2025

Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: insights from an exploratory study.

Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: insights from an exploratory study.

Journal: BMC cancer

Published: December 04, 2025

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

Journal: Brachytherapy

Published: October 29, 2025

Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.

Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.

Journal: Prostate cancer and prostatic diseases

Published: October 20, 2025

Showing 1-12 of 241

Last Updated: 09/26/2026